Inari Medical, Inc.

Good afternoon, everyone, and welcome to the NRE Medical Inc. second quarter 2024 earnings conference call. All participants are in a listen-only mode. At the end of the company's prepared remarks, we will conduct a question and answer session. As a reminder, this call is being recorded and will be available on the company's website for replay shortly. I would now like to turn the floor over to Marissa Beisch.

Ma'am, please go ahead.

Thank you, Operator. Welcome to ANARI's conference call to discuss our second quarter 2024 financial performance. Joining me on today's call are Drew Hikes, President and Chief Executive Officer, and Mitch Hill, Chief Financial Officer. This call includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements including statements related to INARI's estimated full-year 2024 revenue, operating loss or profitability expectations, and the expected operating performance and potential strategic benefits of LIM flow. These statements are based on INARI's current expectations, forecasts, and assumptions, which are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Actual outcomes and results could differ materially from any results, performance, or achievements expressed or implied by the forward-looking statements due to several factors. Please review INARI's most recent filings with the SEC, particularly the risk factors described in our latest Form 10-K for additional information. Any forward-looking statements provided during this call, including projections for future performance, are based on management expectations as of today. INARI undertakes no obligation to update these statements except as required by applicable law. On today's call, we will refer to both GAAP and non-GAAP financial measures in announcing our Q2 2024 results. Please refer to today's press release for a reconciliation of the non-GAAP measure discussed on this call and referred to in that release. The press releases and slides accompanying this call are available on our website at inarimedical.com. A recording of today's call will be available on our website by 5 p.m. Pacific time today. And with that, I'll turn the call over to Drew.